In addition, we demonstrated that fucoidan alleviates myofibroblast activities by targeting the MEG3/miR-181a/Egr1 axis, and this MEG3 network might depend on the type of tissues or pathogenic mechanism (areca nut chewing, diabetes, and inflammation). The gene discussed is MEG3; the disease is diabetes mellitus.